Keyphrases
Pharmacokinetics
69%
Carvedilol
58%
Japanese Patients
44%
Metoprolol
35%
Pharmacokinetic Variability
34%
LS180 Cell
32%
Intestinal Absorption
31%
Oral Clearance
30%
Bisoprolol
30%
Intestinal Epithelial Cells
29%
Caco-2 Cells
27%
CYP2D6*10
24%
Tadalafil
23%
Glucuronidation
21%
Plasma Concentration
21%
NONMEM
20%
Warfarin
20%
Bosentan
20%
Metabolism
19%
P-glycoprotein (P-gp)
19%
Sildenafil
18%
Mizoribine
18%
Ureter
17%
Human Liver Microsomes
17%
Japanese Workers
17%
Ligation
16%
Cytochrome P450 2D6 (CYP2D6)
16%
Carvedilol Enantiomers
15%
Genotype
15%
Sampling Design
15%
Quinidine
14%
Old Japanese
14%
Vitamin K Epoxide Reductase
12%
Renal Failure
12%
Transcellular Transport
12%
Cytochrome P450 3A4 (CYP3A4)
11%
Na +
11%
Absorption Rate
11%
Repeated Dose
11%
Stereoselective Metabolism
11%
α-Naphthoflavone
11%
Hepatic Extraction
11%
Japanese children
11%
Rat Intestine
11%
Dose-response Relationship
11%
Amiodarone
11%
Membrane Transport Mechanism
11%
Levofloxacin
11%
Systemic Clearance
11%
Acute Renal Failure
11%
CYP2C9
11%
Anticoagulant Effect
10%
Elimination Half-life
10%
Inhibitory Effect
9%
Drug Concentration
9%
Inter-individual Variability
9%
Pulmonary Arterial Hypertension
9%
Japanese Pediatric Patients
8%
Polymorphism
8%
CYP2C19
8%
UGT2B7
8%
Incubation
8%
Trough Concentration
8%
LLC-PK1 Cells
8%
Heart Failure
8%
Unbound Fraction
8%
Phosphodiesterase Type 5 Inhibitors
7%
Renal Excretion
7%
Pharmacokinetic Parameters
7%
Genetic Polymorphism
7%
Regression Analysis
7%
CYP3A5
7%
Temperature Effect
7%
CYP2D6 Genotype
7%
Apparent Volume of Distribution
6%
Propranolol
6%
Procainamide
6%
Cytochrome P450 3A (CYP3A)
6%
Ribavirin
6%
Nucleoside Transporters
6%
Population Pharmacokinetics
6%
LLC-PK1
6%
Patients with Heart Failure
6%
Protein Binding
6%
Uptake Transporter
6%
Oral Administration
6%
Peak Concentration
5%
Tetraethylammonium
5%
Maturation Function
5%
Human Serum Proteins
5%
ABCC4
5%
Intensive Care Unit
5%
Cisplatin-induced
5%
Warfarin Dose
5%
Dose Requirement
5%
Flecainide
5%
Cytochrome P450 1A1 (CYP1A1)
5%
Intestinal Microsomes
5%
Stereoselective Oxidation
5%
Inducible Enzymes
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Carvedilol
53%
Metoprolol
35%
CYP2D6
34%
Bisoprolol
30%
Bioavailability
24%
Tadalafil
23%
Warfarin
20%
P-Glycoprotein
19%
Sildenafil
18%
Congestive Heart Failure
16%
Elimination
15%
Bosentan
14%
Quinidine
13%
Kidney Failure
13%
Transcellular Transport
12%
Transcytosis
12%
Mizoribine
12%
Sodium Ion
11%
Cytochrome P450
11%
Dose-Response Relationship
11%
Levofloxacin
11%
Amiodarone
11%
Acute Kidney Failure
11%
CYP3A4
11%
CYP2C19
10%
Messenger RNA
9%
Pulmonary Hypertension
9%
Cytochrome P450 3A5
9%
Drug Concentration
7%
CYP2C9
7%
Renal Excretion
7%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
7%
Anticoagulant Agent
7%
Volume of Distribution
6%
Vitamin K Epoxide Reductase
6%
Propranolol
6%
CYP3A
6%
Procainamide
6%
Ribavirin
6%
Protein Binding
6%
Tetrylammonium
5%
Bepridil
5%
Heart Arrhythmia
5%
Pharmacodynamics
5%
Maintenance Dose
5%
Flecainide
5%
Proton Pump
5%
Phenthoate
5%
Cytochrome P450 1A
5%
Vitamin D Receptor
5%
Cisplatin
5%
Nucleoside
5%
Therapeutic Effect
5%
Histamine
5%
Hypoxia
5%
Paraquat
5%
Phosphodiesterase V Inhibitor
5%
Allergic Reaction
5%
Liver Dysfunction
5%
Toxicity
5%
Tacrolimus
5%
Bovine Serum Albumin
5%
Risperidone
5%
Pharmacogenetics
5%
Lansoprazole
5%
Table Salt
5%
Plasma Protein
5%
Protein Losing Gastroenteropathy
5%
Pharmacokinetic Parameter
5%
Glycylsarcosine
5%
Effusion
5%